Cheng J M, Hiemstra J L, Schneider S S, Kaufman B A, Naumova A, Cheung N K, Cohn S L, Diller L, Sapienza C, Brodeur G M
Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Prog Clin Biol Res. 1994;385:43-9.
There is increasing evidence that imprinting plays an important role in influencing the parental origin of genes involved in cancer-specific rearrangements. In advanced stage neuroblastomas, both allelic loss of the short arm of chromosome 1 (1p) and amplification of the proto-oncogene N-myc are often seen. Therefore, we analyzed 22 human neuroblastomas with N-myc amplification to determine the parental origin of the N-myc allele that is amplified and the 1p allele that is deleted. We used at least three polymorphisms for both the 1p and the N-myc locus to analyze blood and tumor samples from neuroblastoma patients, as well as blood samples from their parents. We determined that the paternal allele of N-myc was amplified in 12 of 15 informative cases (P = 0.02), and the paternal allele on 1p was lost in 6 of 11 informative cases (P > 0.2). These results suggest that parental imprinting does not appear to affect the 1p allele that is deleted, at least in the cases that we have examined. However, imprinting has an important influence on determining the N-myc allele that is amplified in these tumors, suggesting that the paternal allele is either more highly expressed or more likely to undergo amplification.
越来越多的证据表明,印记在影响参与癌症特异性重排的基因的亲本来源方面起着重要作用。在晚期神经母细胞瘤中,经常可以看到1号染色体短臂(1p)的等位基因缺失和原癌基因N - myc的扩增。因此,我们分析了22例具有N - myc扩增的人类神经母细胞瘤,以确定扩增的N - myc等位基因和缺失的1p等位基因的亲本来源。我们对1p和N - myc基因座均使用了至少三种多态性来分析神经母细胞瘤患者的血液和肿瘤样本以及他们父母的血液样本。我们确定,在15例信息充足的病例中有12例N - myc的父本等位基因被扩增(P = 0.02),在11例信息充足的病例中有6例1p上的父本等位基因缺失(P > 0.2)。这些结果表明,至少在我们所研究的病例中,亲本印记似乎并不影响缺失的1p等位基因。然而,印记对确定这些肿瘤中扩增的N - myc等位基因具有重要影响,这表明父本等位基因要么表达水平更高,要么更有可能发生扩增。